Zevra’s Arimoclomol Use With Standard Of Care Complicates US FDA Adcomm Efficacy Assessment

 
• By Sue Sutter
  
Knot
The FDA's advisors found it difficult to untangle the efficacy of arimoclomol from miglustat. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers